If our results are confirmed in a large-scale prospective study, we believe that not only do patients with cardiovascular diseases have a much higher chance of recovery than previously appreciated, but that their chances might increase to near 100%, since they could receive continuous medical care from their doctors with the ultimate aim of curing their diseases.
Common treatments for cardiovascular conditions include antihypertensive medications, statins, and anticoagulants. There are numerous possible medical solutions for cardiovascular conditions, as there are myriad causes. It can be difficult to identify what's causing the condition, so it may be very important for patients to consult with a physician to evaluate and develop treatment plans. Understanding what's necessary for treatment, especially in patients with complex medical problems, may be challenging but necessary in the process of treating the disease.
All signs related to cardiovascular diseases (e.g. hypertension, diabetes, dyslipidemia, obesity and smoking) have been reported to be of higher prevalence in developing countries, which is probably due to unhealthy lifestyles amongst the local population. The findings of our study have shown that dyslipidemia was the most prevalent heart disease.
About 6 million people in the US have at least one CV disease. The American Heart Association has estimated that more than 7 million people will die of heart disease in 2030, and more than 5 million people will die of stroke unless risk factor prevention or improvements in medical care are made. The following table presents the estimate of how many people will suffer from various types of CV disease and the incidence of CVD in the United States (1999 as basis).
It is the most likely reason behind death to have cardiovascular diseases. As they are most prevalent in developed and intermediate countries, it is expected that high-risk populations should be a major focus as it is thought that cardiovascular diseases can be avoided when diagnosed early enough.
A number of cardiovascular conditions are autosomal dominant in many different families including coronary artery disease and myocardial infarction. Most families in which disease runs are also aware of related members such as a grandmother or other close family member suffering from the same disease.
With the development of better understanding of the importance of polyphenols and the health benefits of their antioxidant and anti-inflammatory properties, the incorporation of these polyphenols into food can give consumers a way of lowering the risk of CAD/diet-related disorders while also being more comfortable with their overall diet.
Our meta-analysis shows that a MedDiet is efficient in treating cardiovascular disease. Results from a recent paper also suggest that some aspects of the diet may be more effective than others in the control of cardiovascular diseases. Moreover, our results are in accordance with a MedDiet's beneficial effects on overall mortality, such as cancer prevention and treatment.
Despite the long history of cardiovascular disease, the pathophysiological mechanisms and drug targets have not changed at all. New treatments, however, have been discovered lately. The focus is now on the development of treatments for atherosclerosis, hypertension, thrombosis, cerebrovascular disease, and cardiac arrhythmia. There are many opportunities to create drugs and to develop new therapies. Examples of the possible opportunities for clinical trials are listed below. A new and exciting approach for treating hypertension is using agents on the β₂-agaritine family and their analogues in clinical trials. Also, there is a growing focus on the role of nitric oxide in cardiovascular ailments.